RESUMEN
Rasa Shastra is a branch which deals with mercury, metals, minerals, gems, herbal drugs and various principles of alchemy and metallurgy. The popular books on Kerala Ayurvedic treatment like Sahasrayoga and Chikitsamanjari describes various potent herbomineral formulations. One such Kharaleeya rasayana yoga is Chukkumthippalyadi gulika explained in Jwaraprakarana of Chikitsamanjari. This Yoga has a wide range of therapeutic utility and indicated in Tridoshaja sannipathika jwara. Jwara is the first and the most serious of all diseases so it needs to be specially attended. Ingredients in the formulation include drugs from Maharasa, Uparasa and Sadharana rasa vargikarana of Rasa dravyas which are to be used in the formulation after proper Samskaras like Sodhana and Marana. Few other controversial drugs like Gandhamarjaraveerya, and Mrigasringa are also included in the formulation. Other herbal ingredients include Sunti, Pippali, Bola, Vacha, Jeeraka, Rudraksha, Kiratatikta and Karpoora. Indication of the Yoga specifies Haret Drak Sannipathajwaram depicts its immediate action on Jwarachikitsa. Aims and Objective: The main objective of this article is to discuss the therapeutic uses of Chukkumthippalyadi gulikaand to discuss the different pharmacological properties and therapeutic uses of isolated constituent drugs of Chukkumthippalyadi gulika thus to raise an awareness of this particular formulation in the healthcare system so that they can be applied to community needs. Discussion: Most of the drug in Chukkumthippalyadi gulika is Katu, Tikta rasatmak with Ushna Veerya, Laghu, Ruksha, and Tikshna Gunatmak having Jwarghna property. Conclusion: Chukkumthippalyadi gulika is a very effective drug, it has multidimensional broad spectrum activity so this can be used in all type of Jwara.
RESUMEN
Though many cancer alternative therapies are popular in India, however, few have been accepted by the convention oncology forum to be effective. The metal based Ayurvedic protocol developed by Vaidya Chandra Prakash and later popularised by his son Vaidya Balendu Prakash is one of such cancer alternative therapy. The first successful treatment of a Hodgkin’s Lymphoma patient with bone metastasis was reported in 1960 with an Ayurvedic preparation called Valipani developed by Vaidya Chandra Prakash. Valipani contained processed mercury, sulphur, iron, harar (Terminalia Chebula) along with bhilava (Semecarpus anacardium), amla (Emblica officinalis), ginger and honey, which was primarily given to the patient to strengthen the bone marrow function. However, the results could not be repeated with the new batch of Valipani, may be because of some problems associated with the medicine preparation. Similar situation was also encountered with another metal based preparation called Amar. In 1980s a new metal based formulation called Navjeevan was prepared and it was found to be effective in the treatment of Myeloma and Lymphoma. In 1984 Vaidya Chandra Prakash passed away, it was then Vaidya Balendu Prakash who convinced the medical fraternity to accept his claims. Later, he patented his formulation and also present 13 successfully treated cancer patients for the ‘Best Case Series’ presentation in National Cancer Institute, USA. The evolution of this alternative metal based Ayurvedic therapy for cancer treatment is discussed.
RESUMEN
A 47 year old diabetic male patient was diagnosed and treated for high risk AML-M3 at Tata Memorial Hospital (BJ 17572), Mumbai in September 1995. His bone marrow aspiration cytology indicated 96% promyelocytes with abnormal forms, absence of lymphocytic series and myeloperoxide test 100% positive. Initially treated with ATRA, he achieved hematological remission on day 60, but cytogenetically the disease persisted. The patient received induction and consolidated chemotherapy with Daunorubicin and Cytarabine combination from 12.01.96 to 14.05.96, following which he achieved remission. However, his disease relapsed in February 97. The patient was given two cycles of chemotherapy with Idarubicine and Etoposide, after which he achieved remission. His disease again relapsed in December 97. The patient then refused more chemotherapy and volunteered for a pilot Ayurvedic study conducted by the Central Council for Research in Ayurveda and Siddha, New Delhi. The patient was treated with a proprietary Ayurvedic medicine Navajeevan, Kamadudha Rasa and Keharuba Pisti for one year. For the subsequent 5 years the patient received three months of intermittent Ayurvedic treatment every year. The patient achieved complete disease remission with the alternative treatment without any adverse side effects. The patient has so far completed 13 years of survival after the start of Ayurvedic therapy.